What claims should I avoid on lip balm in the USA to stay in “cosmetic” territory?

To keep a lip balm in US "cosmetic" territory, avoid drug-type claims (treating, healing, preventing, or curing conditions) and any SPF/sunscreen claims unless you are ready for OTC drug compliance. Stick to appearance- and feel-based benefits like moisturizing, smoothing, and conditioning.

US buyer view Launch planning Updated: January 27, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • In the USA, lip balm stays a cosmetic when your claims focus on cleansing/beautifying/altering appearance, not treating disease or affecting body structure/function.
  • Avoid: “heals cracked lips,” “treats eczema/dermatitis,” “cold sore/antiviral,” “anti-inflammatory,” “pain relief,” “medicated,” “clinically cures,” and any “SPF” or “sunblock” claims (those typically trigger OTC drug requirements).
  • Also avoid “FDA approved” or implying regulatory endorsement.
  • Safer cosmetic phrasing: “moisturizes,” “conditions,” “softens,” “smooths,” “adds shine,” “helps lips feel less dry,” and “supports a healthy-looking lip appearance.” If you want a repair or medical positioning, we can discuss an alternative pathway and supporting documentation/testing.
  • For OEM/ODM, we can customize formula and provide lab samples in ~7-10 business days.
  • Typical MOQ is flexible (often 1,000-5,000 units per SKU depending on packaging like stick, tube, or jar), with bulk production lead time ~25-35 days after final formula/pack approval.
  • We can support documentation (COA/MSDS, ingredient breakdown) and coordinate stability/micro testing, plus packaging/VI design, barcode support, and logistics guidance without guaranteeing regulatory approval.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).